(3-(1H-NAPHTHO[1,8-DE][1,3,2]DIAZABORININ-2(3H)-YL)PHENYL)BORONIC ACID PINACOL ESTER, 95.0%, 1g

[S(R)]-N-[(S)-[4-(1,1-Dimethylethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-2-methyl-2-propanesulfinamide, 95%, 50mg

3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)propanoic acid, 97.0%, 250mg

Pt- cis-Dichlorodiamine platinum(II) 1 g

3-Methylenecyclobutanecarbonitrile, 98.0%, 10g

1,2-Bis(4-(benzo[d]oxazol-2-yl)phenyl)ethene, 500g

Plan strain-free PLPOLi 10x/0.25 IOS objective for iScope transmitted polarization, no cover glass correction. Working distance 10 mm

2,2',7,7'-Tetrakis-(N,N-di-4-methoxyphenylamino)-9,9'-spirobifluorene>98.0%(HPLC)1g

Di-p-tolyl Disulfide>98.0%(GC)25g

Triphenyl(prop-2-yn-1-yl)phosphonium bromide, 97%, 25g

1-propyl-1H-benzimidazole-2-thiol, 95.0%, 1g

3-METHYLBENZOYL CYANIDE, 95.0%, 250mg

6-Chloro-5-iodo-3-nitropyridin-2-amine, 95.0%, 250mg